Olson Research Group and Currant Insights recently partnered to better understand rare disease stakeholder dynamics.
After an initial round of exploratory research focused on three rare conditions, we expanded the research scope to survey 845 physicians treating ten rare conditions to further test our hypothesis and refine our model. Results from the research were presented at the 2014 PMRG Institute. This infographic details three key insights into rare disease stakeholder dynamics.
